)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Vaxart
Vaxart (VXRT) investor relations material
Vaxart Global BioInnovation Forum 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Global BioInnovation Forum 2026 summary13 Jan, 2026
Innovation in vaccine delivery
Focus on oral recombinant pill vaccines to replace traditional injections, aiming for greater convenience and accessibility.
Technology leverages mucosal immunology to induce IgA antibodies at pathogen entry points, enhancing cross-protection.
Platform allows rapid adaptation to new pathogens by inserting genes of interest into a stable adenoviral vector.
Tablets are thermostable, easy to distribute, and eliminate the need for cold chain logistics and medical waste.
Oral vaccines can be self-administered, increasing global access and potentially improving vaccination rates.
Clinical and preclinical data highlights
Preclinical studies in animal models demonstrated reduced transmission and cross-protection against multiple strains.
Norovirus challenge studies showed prevention of infection and robust immune responses in diverse populations, including lactating mothers and the elderly.
COVID-19 oral vaccine produced strong mucosal and T-cell responses in phase 1 trials.
Influenza oral vaccine reduced symptomatic infection more than a leading injected vaccine in head-to-head studies.
Safety profile across nearly 1,200 subjects is comparable to placebo, with no injection site reactions.
Forward-looking statements and upcoming milestones
Top-line results from a 400-person COVID-19 trial comparing oral and mRNA vaccines expected in Q1 2026.
Larger 5,000-subject COVID-19 trial results anticipated in late 2026.
Phase 2b norovirus vaccine study could begin as early as 2026, following strong head-to-head data.
Ongoing development of seasonal and avian influenza programs, leveraging rapid platform adaptability.
Emphasis on the potential for the oral platform to revolutionize vaccine distribution and acceptance.
How does mucosal immunity enhance vaccine protection?
What are the expected COVID-19 trial results in 2026?
How do oral vaccines improve global health access?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Vaxart earnings date
Q4 202519 Mar, 2026
Vaxart
Next Vaxart earnings date
Q4 202519 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Vaxart Inc. is a biotechnology company focused on developing oral vaccines that are administered using tablet formulations rather than injections. The company's proprietary oral vaccine platform is designed to stimulate immune responses in mucosal tissues, which are the first line of defense against many infections. Vaxart's vaccine candidates target a range of infectious diseases, including influenza, norovirus, and COVID-19. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage